Papers in Heart Drug
Page 2 · newest first
- Rate versus Rhythm Control – An Open and Shut Case?Heart Drug · 2003
- The Influence of Multiple Variables on the Prevalence of Aspirin Prescribing in Patients with Known Coronary Artery DiseaseHeart Drug · 2003
- Utility of the Combination of Echocardiography and Troponin T Test in Patients with ST Segment DepressionHeart Drug · 2002
- Left Ventricular Hypertrophy in HypertensionHeart Drug · 2002
- New Approaches to Treatment of Acute Myocardial Infarction: Combination Antiplatelet and Fibrinolytic TherapyHeart Drug · 2002
- Should Heart Failure Be Treated with Antithrombotic Drugs?Heart Drug · 2002
- Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular EventsHeart Drug · 2002
- Exercise-Induced ST Depression as a Prognostic Indicator of Cardiac Morbidity in Thrombolytic-Treated Post-Myocardial Infarction Patients with Silent IschemiaHeart Drug · 2002
- Cardiovascular Manifestations of Thyroid DiseaseHeart Drug · 2002
- n–3 Fatty Acids and Cardiovascular DiseaseHeart Drug · 2002
- Effect of Beta-Blockade on Heart Rate and VO₂ Kinetics during Recovery in Patients with Coronary Artery DiseaseHeart Drug · 2002
- Irbesartan in Primary Hypertension in Thai Patients: A Multicentre, Non-Comparative StudyHeart Drug · 2002
- Heart Failure in the Elderly: Characteristics of a Swedish Primary Health Care PopulationHeart Drug · 2002
- Is Heart Rate Reduction Beneficial to Patients with Chronic Congestive Heart Failure?Heart Drug · 2002
- Clopidogrel – Confounding or Confirming Our Concept of How to Treat Acute Coronary Syndromes?Heart Drug · 2002
- Economical Aspects of High-Sensitivity C-Reactive Protein as Predictor of Coronary Heart DiseaseHeart Drug · 2002
- Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart FailureHeart Drug · 2002
- Cardiac Positron Emission TomographyHeart Drug · 2002
- Intravascular Ultrasound: Technique, Measurements and Angioplasty GuidanceHeart Drug · 2002
- The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background PopulationHeart Drug · 2002
- Logistics of Primary AngioplastyHeart Drug · 2002
- Warfarin: Mechanisms for Durable Effects in Coronary Artery DiseaseHeart Drug · 2002
- Acute Coronary Syndrome and Early Statin Therapy: What Is the Evidence?Heart Drug · 2002
- Prior Aspirin Therapy, Subsequent Stroke Severity and Mortality and Relationship with Cardiovascular Risk Factors in Patients Admitted to Hospital with Acute StrokeHeart Drug · 2002
- NF-κB as a Therapeutic Target for Cardiovascular DiseaseHeart Drug · 2002
- Reduction of QT Dispersion by Losartan in Patients with Mild to Moderate HypertensionHeart Drug · 2002
- Gold Standard Treatment of Carotid Stenosis: Carotid Surgery or Stent?Heart Drug · 2002
- Warfarin Therapy in Acute Coronary SyndromesHeart Drug · 2002
- EARTH: EndothelinA Receptor Antagonist Trial in Heart FailureHeart Drug · 2001
- Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic AgentHeart Drug · 2001
- Effect of Beta-Blockade on Postexercise Oxygen Uptake Kinetics in Patients with Chronic Heart FailureHeart Drug · 2001
- Morbidity of Post-Coronary Artery Bypass Surgery Patients with Atrial Fibrillation Treated with Rate Control versus Sinus-Restoring TherapyHeart Drug · 2001
- Dependency on Infarct Size Limits the Clinical Applicability of Non-Invasive Reperfusion Assessment by Biochemical Markers in Acute Myocardial InfarctionHeart Drug · 2001
- Standardization of Central Off-Line Quantitative Image Analysis: Implications from Experiences with Quantitative Coronary AngiographyHeart Drug · 2001
- Biomarkers and Exercise Training: A Possible Missing Link between Physical Activity and Mortality Benefit in Patients with Heart FailureHeart Drug · 2001
- Vasopeptidase Inhibitors: A New Class of DrugsHeart Drug · 2001
- Transmyocardial Laser Revascularization: Established Procedure, Acupuncture of the Heart or Placebo Effect?Heart Drug · 2001
- Platelets and Thrombolysis: Cooperation or Contrariety?Heart Drug · 2001
- Variable Interindividual Responses to Antiplatelet Therapies – Do They Exist, Can We Measure Them, and Are They Clinically Relevant?Heart Drug · 2001
- Observations on the Use of Low-Dose Hydrochlorothiazide in the Treatment of Hypertension in Diabetic NigeriansHeart Drug · 2001
- Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial InfarctionHeart Drug · 2001
- Optimizing Reperfusion Therapy: Adjunct Use of Glycoprotein IIb/IIIa Antagonists with Fibrinolytic Therapy in Acute Myocardial InfarctionHeart Drug · 2001
- Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial InfarctionHeart Drug · 2001
- Surrogate End Points of Antihypertensive Treatment: Left Ventricular Hypertrophy and Structural Alteration of Carotid ArteriesHeart Drug · 2001
- Incidence of and Predicting Factors for Torsades de Pointes during Intravenous Administration of AmiodaroneHeart Drug · 2001
- Amiodarone: The Last and/or Best Hope for Pharmacological Control of Cardiac Arrhythmias?Heart Drug · 2001
- Neutral Peptidase InhibitorsHeart Drug · 2001
- Long-Term Treatment with Angiotensin-Converting Enzyme Inhibitors, Beta-Blockers or a Combination of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Low-Risk Patients after Acute Myocardial Infarction: The ABC StudyHeart Drug · 2001
- Effect of ‘Drug Holiday’ on Blood Pressure Control: A Randomized Double-Blind Comparative Trial of Amlodipine versus Felodipine Extended Release in Chinese Patients with Mild to Moderate Essential HypertensionHeart Drug · 2001
- Glycoprotein IIb/IIIa Inhibitors in Acute Coronary SyndromesHeart Drug · 2001